“…Of the 17 papers included in the review 3 were literature reviews [8,14,17], 1 was a mixed method study [22], 6 were retrospective cohort studies [23][24][25][26][27][28], 1 was a case control study [29], 4 were cross sectional studies [7,15,30,31], 2 qualitative studies [32,33]. Study populations were heterogenic and 3 studies included patients with a variety of cancers including sarcoma [22,26,28], 1 with both primary bone and soft tissue sarcomas [30], 7 with 100% soft tissue sarcoma patients [7,8,14,17,24,27,29] and 6 studies with 100% primary bone sarcoma patients [15,23,25,[31][32][33]. The age of study populations also varied with 5 studies reporting the results of adolescents and adults under the age of 35 years.…”